Article
Genotypes of vitamin K epoxide reductase, gamma-glutamyl carboxylase, and cytochrome P450 2C9 as determinants of daily warfarin dose in Japanese patients.
Thrombosis research - 1 Jan 2007
Kimura Rina, Miyashita Kotaro, Kokubo Yoshihiro, Akaiwa Yasuhisa, Otsubo Ryoichi, Nagatsuka Kazuyuki, Otsuki Toshiho, Okayama Akira, Minematsu Kazuo, Naritomi Hiroaki, Honda Shigenori, Tomoike Hitonobu, Miyata Toshiyuki
Abstract excerpt
The dose required for the anticoagulant effect of warfarin exhibits large inter-individual variations. This study sought to determine the contribution of four genes, vitamin K epoxide reductase (VKORC1), gamma-glutamyl carboxylase (GGCX), calumenin (CALU), and cytochrome P450 2C9 (CYP2C9) to the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
